COVID-19 Research: Navigating the European General Data Protection Regulation

被引:2
|
作者
Becker, Regina [1 ]
Thorogood, Adrian [2 ]
Ordish, Johan [3 ]
Beauvais, Michael J. S. [2 ]
机构
[1] Univ Luxembourg, Luxembourg Ctr Syst Biomed LCSB, ELIXIR Luxembourg, Campus Belval,7 Ave Hauts Fourneaux, L-4362 Esch Sur Alzette, Luxembourg
[2] McGill Univ, Ctr Genom & Policy, Montreal, PQ, Canada
[3] Univ Cambridge, PHG Fdn, Cambridge, England
基金
加拿大健康研究院;
关键词
COVID-19; GDPR; health research; pandemic; data privacy; data protection; regulation;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Researchers must collaborate globally to rapidly respond to the COVID-19 pandemic. In Europe, the General Data Protection Regulation (GDPR) regulates the processing of personal data, including health data of value to researchers. Even during a pandemic, research still requires a legal basis for the processing of sensitive data, additional justification for its processing, and a basis for any transfer of data outside Europe. The GDPR does provide legal grounds and derogations that can support research addressing a pandemic, if the data processing activities are proportionate to the aim pursued and accompanied by suitable safeguards. During a pandemic, a public interest basis may be more promising for research than a consent basis, given the high standards set out in the GDPR. However, the GDPR leaves many aspects of the public interest basis to be determined by individual Member States, which have not fully or uniformly made use of all options. The consequence is an inconsistent legal patchwork that displays insufficient clarity and impedes joint approaches. The COVID-19 experience provides lessons for national legislatures. Responsiveness to pandemics requires clear and harmonized laws that consider the related practical challenges and support collaborative global research in the public interest. (J Med Internet Res 2020;22(8):e19799) doi: 10.2196/19799
引用
收藏
页数:9
相关论文
共 50 条